Role for chitin and chitooligomers in the capsular architecture of cryptococcus neoformans∇

Eukaryotic Cell

Volumn 8, Issue 10, 2009, Pages 1543-1553

  Fonseca, Fernanda L ^a   Nimrichter, Leonardo ^a   Cordero, Radames J B ^a   Frases, Susana ^a   Rodrigues, Jessica ^a   Goldman, David L ^a,b   Andruszkiewicz, Ryszard ^b   Milewski, Slawomir ^b   Travassos, Luiz R ^c,e   Casadevall, Arturo ^a,d   Rodrigues, Mareio L ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Universidade Federal do Rio de Janeiro ^*

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHITIN; OLIGOSACCHARIDE;

ARTICLE; CELL WALL; CHEMISTRY; CRYPTOCOCCUS NEOFORMANS; CYTOLOGY; FLUORESCENCE MICROSCOPY; METABOLISM; SCANNING ELECTRON MICROSCOPY;

CELL WALL; CHITIN; CRYPTOCOCCUS NEOFORMANS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; OLIGOSACCHARIDES;

FILOBASIDIELLA NEOFORMANS; FUNGI; RATTUS; TRITICUM AESTIVUM;

EID: 70349687724     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00142-09     Document Type: Article

References (37)

1. Baker, L. G., C. A. Specht, M. J. Donlin, and J. K. Lodge. 2007. Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot. Cell 6:855-867.
2. Banks, I. R., C. A. Specht, M. J. Donlin, K. J. Gerik, S. M. Levitz, and J. K. Lodge. 2005. A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot. Cell 4:1902-1912.
3. Bicanic, T., and T. S. Harrison. 2004. Cryptococcal meningitis. Br. Med. Bull. 72:99-118.
4. Boot, R. G., E. F. Blommaart, E. Swart, K. Ghauharali-van der Vlugt, N. Bijl, C. Moe, A. Place, and J. M. Aerts. 2001. Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J. Biol. Chem. 276:6770-6778.
5. Casadevall, A., W. Cleare, M. Feldmesser, A. Glatman-Freedman, D. L. Goldman, T. R. Kozel, N. Lendvai, J. Mukherjee, L. A. Pirofski, J. Rivera, A. L. Rosas, M. D. Scharff, P. Valadon, K. Westin, and Z. Zhong. 1998. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob. Agents Chemother. 42:1437-1446.
6. Casadevall, A., J. Mukherjee, and M. D. Scharff. 1992. Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J. Immunol. Methods 154: 27-35.
7. Chang, Y. C., and K. J. Kwon-Chung. 1994. Complementation of a capsuledeficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14:4912-4919.
8. Chang, Y. C., and K. J. Kwon-Chung. 1998. Isolation of the third capsuleassociated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect. Immun. 66:2230-2236.
9. Chang, Y. C., L. A. Penoyer, and K. J. Kwon-Chung. 1996. The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect. Immun. 64:1977-1983.
10. Dykstra, M. A., L. Friedman, and J. W. Murphy. 1977. Capsule size of Cryptococcus neoformans: control and relationship to virulence. Infect. Immun. 16:129-135.
11. Eisenman, H. C., J. D. Nosanchuk, J. B. Webber, R. J. Emerson, T. A. Camesano, and A. Casadevall. 2005. Microstructure of cell wall-associated melanin in the human pathogenic fungus Cryptococcus neoformans. Biochemistry 44:3683-3693.
12. Fonseca, F. L., S. Frases, A. Casadevall, O. Fischman-Gompertz, L. Nimrichter, and M. L. Rodrigues. 2009. Structural and functional properties of the Trichosporon asahii glucuronoxylomannan. Fungal Genet. Biol. 46:496-505.
13. Frases, S., L. Nimrichter, N. B. Viana, A. Nakouzi, and A. Casadevall. 2008. Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot. Cell 7:319-327.
14. Frases, S., B. Pontes, L. Nimrichter, N. B. Viana, M. L. Rodrigues, and A. Casadevall. 2009. Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules. Proc. Natl. Acad. Sci. USA 106:1228-1233.
15. Guoping, C., P. Fan, S. Jingxi, L. Xiaoping, J. Shiqin, and L. Yuri. 1997. Purification and characterization of a silica-induced bronchoalveolar lavage protein with fibroblast growth-promoting activity. J. Cell Biochem. 67:257-264. (Pubitemid 27431170)
16. Kozel, T. R., S. M. Levitz, F. Dromer, M. A. Gates, P. Thorkildson, and G. Janbon. 2003. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infect. Immun. 71:2868-2875.
17. Li, R. K., and M. G. Rinaldi. 1999. In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole. Antimicrob. Agents Chemother. 43:1401-1405.
18. Maxson, M. E., E. Cook, A. Casadevall, and O. Zaragoza. 2007. The volume and hydration of the Cryptococcus neoformans polysaccharide capsule. Fungal Genet. Biol. 44:180-186.
19. McFadden, D., O. Zaragoza, and A. Casadevall. 2006. The capsular dynamics of Cryptococcus neoformans. Trends Microbiol. 14:497-505.
20. McFadden, D. C., M. De Jesus, and A. Casadevall. 2006. The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction. J. Biol. Chem. 281:1868-1875.
21. Milewski, S., R. Andruszkiewicz, L. Kasprzak, J. Mazerski, F. Mignini, and E. Borowski. 1991. Mechanism of action of anticandidal dipeptides containing inhibitors of glucosamine-6-phosphate synthase. Antimicrob. Agents Chemother. 35:36-43.
22. Milewski, S., H. Chmara, R. Andruszkiewicz, E. Borowski, M. Zaremba, and J. Borowski. 1988. Antifungal peptides with novel specific inhibitors of glucosamine 6-phosphate synthase. Drugs Exp. Clin. Res. 14:461-465.
23. Milewski, S., I. Gabriel, and J. Olchowy. 2006. Enzymes of UDP-GlcNAc biosynthesis in yeast. Yeast 23:1-14.
24. Mitchell, D. H., T. C. Sorrell, A. M. Allworth, C. H. Heath, A. R. McGregor, K. Papanaoum, M. J. Richards, and T. Gottlieb. 1995. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin. Infect. Dis. 20:611-616.
25. Monari, C., F. Bistoni, and A. Vecchiarelli. 2006. Glucuronoxylomannan exhibits potent immunosuppressive properties. FEMS Yeast Res. 6:537-542. (Pubitemid 43725737)
26. Murray, S. B., and A. C. Neville. 1998. The role of pH, temperature and nucleation in the formation of cholesteric liquid crystal spherulites from chitin and chitosan. Int. J. Biol. Macromol. 22:137-144.
27. Nimrichter, L., S. Frases, L. P. Cinelli, N. B. Viana, A. Nakouzi, L. R. Travassos, A. Casadevall, and M. L. Rodrigues. 2007. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot. Cell 6:1400-1410.
28. Overdijk, B., G. J. Van Steijn, and F. C. Odds. 1999. Distribution of chitinase in guinea pig tissues and increases in levels of this enzyme after systemic infection with Aspergillus fumigatus. Microbiology 145:259-269. (Pubitemid 29043598)
29. Reese, A. J., and T. L. Doering. 2003. Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol. Microbiol. 50:1401-1409.
30. Reese, A. J., A. Yoneda, J. A. Breger, A. Beauvais, H. Liu, C. L. Griffith, I. Bose, M. J. Kim, C. Skau, S. Yang, J. A. Sefko, M. Osumi, J. P. Latge, E. Mylonakis, and T. L. Doering. 2007. Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence. Mol. Microbiol. 63:1385-1398.
31. Rivera, J., M. Feldmesser, M. Cammer, and A. Casadevall. 1998. Organdependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infect. Immun. 66:5027-5030.
32. Rodrigues, M. L., M. Alvarez, F. L. Fonseca, and A. Casadevall. 2008. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot. Cell 7:602-609.
33. Rodrigues, M. L., F. L. Fonseca, S. Frases, A. Casadevall, and L. Nimrichter. 3 April 2009. The still obscure attributes of cryptococcal glucuronoxylomannan. Med. Mycol. doi:10.1080/13693780902788621. [Epub ahead of print.]
34. Rodrigues, M. L., S. Rozental, J. N. Couceiro, J. Angluster, C. S. Alviano, and L. R. Travassos. 1997. Identification of A'-acetylneuraminic acid and its 9-O-acetylated derivative on the cell surface of Cryptococcus neoformans: influence on fungal phagocytosis. Infect. Immun. 65:4937-4942.
35. Rodrigues, M. L., L. R. Travassos, K. R. Miranda, A. J. Frenzen, S. Rozental, W. de Souza, C. S. Alviano, and E. Barreto-Bergter. 2000. Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. Infect. Immun. 68:7049-7060.
36. Siafakas, A. R., T. C. Sorrell, L. C. Wright, C. Wilson, M. Larsen, R. Boadle, P. R. Williamson, and J. T. Djordjevic. 2007. Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity. J. Biol. Chem. 282:37508-37514.
37. Vicencio, A. G., S. Narain, Z. Du, W. Y. Zeng, J. Ritch, A. Casadevall, and D. L. Goldman. 2008. Pulmonary cryptococcosis induces chitinase in the rat. Respir. Res. 9:40.